A Multicentre, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis

Hodge, Alex (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA Reference Number: HREC/16/SVHM/78
SSA Reference Number: SSA/16/MonH/329
Monash Health HREC Ref: RES-16-0000-488X

Status	Finished
Effective start/end date	1/07/19 → 30/06/24

Keywords

clinical trial
treatment efficacy
hepatitis
fibrosis

Clinical Trial Phase

Phase III (a & b)